LabMD, Inc. Oral Argument Before the Commission

AGENCY:

Federal Trade Commission.

ACTION:

Oral argument; open meeting.

SUMMARY:

The Federal Trade Commission (“FTC” or “Commission”) will meet on Tuesday, March 8, 2016, in Room 532 of the FTC Building for an Oral Argument In the Matter of LabMD, Inc. The public is invited to attend and observe the open portion of the meeting, which is scheduled to begin at 1:00 p.m. The remainder of the meeting will be closed to the public.

DATES:

Oral argument is scheduled for March 8, 2016 at 1:00 p.m.

ADDRESSES:

Federal Trade Commission Building, 600 Pennsylvania Avenue NW., Washington, DC 20580.

FOR FURTHER INFORMATION CONTACT:

Donald S. Clark, Secretary, Office of the Secretary, 600 Pennsylvania Avenue NW., Washington, DC 20580, 202-326-2515.

SUPPLEMENTARY INFORMATION:

Open Meeting

(1) Oral Argument In the Matter of LabMD, Inc., Docket No. 9357.

Closed Meeting

(2) Executive Session to follow Oral Argument In the Matter of LabMD, Inc., Docket No. 9357.

Record of Commission's Vote

On January 20, 2016, Commissioners Ramirez, Ohlhausen, and McSweeny were recorded as voting in the affirmative to close Matter Number (2), and to withhold from this meeting notice such information as is exempt from disclosure under 5 U.S.C. 552b(c)(10). Commissioner Brill was recorded as not participating.

Commission's Explanation of Closing

The Commission has determined that Matter Number (2) may be closed under 5 U.S.C. 552b(c)(10), and that the public interest does not require the matter to be open.

General Counsel Certification

The General Counsel has certified that Matter Number (2) may properly be closed, citing the following relevant provision: 5 U.S.C. 552b(c)(10).

Expected Attendees

Expected to attend the closed meeting are the Commissioners themselves, an advisor to one of the Commissioners, and such other Commission staff as may be appropriate.